combination tremelimumab and durvalumab in hcc
Published 4 years ago • 239 plays • Length 7:47Download video MP4
Download video MP3
Similar videos
-
2:33
emerald-3: tremelimumab durvalumab with or without lenvatinib combined with tace in hcc
-
1:02
evaluating real-world efficacy of durvalumab and tremelimumab in hcc
-
4:56
himalaya: tremelimumab durvalumab in unresectable hcc
-
3:34
himalaya: does underlying liver function impact efficacy of tremelimumab plus durvalumab for hcc?
-
4:56
himalaya: tremelimumab durvalumab in unresectable hcc
-
1:15
montblanc: sequential or up-front durvalumab, tremelimumab, bevacizumab in unresectable hcc
-
3:26
infinty: tremelimumab and durvalumab in msi-high gc/gejc
-
2:39
tebentafusp in combination with durvalumab and/or tremelimumab in metastatic cutaneous melanoma
-
7:48
himalaya: study of tremelimumab and durvalumab as first-line therapy in patients with uhcc
-
2:10
poseidon: 4 year follow up of durvalumab and tremelimumab in nsclc
-
3:57
katie kelley, md, discusses fitting tremelimumab durvalumab into hcc treatment algorithms
-
2:12
dutreneo: durvalumab and tremelimumab vs chemo
-
3:48
poseidon: durvalumab /- tremelimumab chemo in 1l mnsclc
-
2:03
tremelimumab and durvalumab therapy in lung cancer
-
4:53
checkpoint inhibition in hepatocellular carcinoma
-
44:01
webinar: combination of durvalumab, bevacizumab, tremelimumab & transarterial chemoembolization
-
0:43
double immunotherapy with durvalumab and tremelimumab versus quadruple therapy in nsclc
-
1:27
durigast: 2l folfiri plus durvalumab plus tremelimumab in gc or ge junction adenocarcinoma
-
1:22
the current treatment landscape and future directions of combination approaches for hcc